The FDA recently approved the first treatment in nearly 30 years for acute stroke, and the agency also approved a novel drug ...
Clearance of Vykat unlocks what analysts anticipate will be a lucrative market opportunity for Soleno Therapeutics.
The agency OK’d an artificial vessel to restore blood flow in patients, even though its own scientists flagged questionable ...